Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1984342562', 'doi': 'https://doi.org/10.1586/14779072.5.1.45', 'title': 'Platelet P2 receptors: old and new targets for antithrombotic drugs', 'display_name': 'Platelet P2 receptors: old and new targets for antithrombotic drugs', 'publication_year': 2007, 'publication_date': '2007-01-01', 'ids': {'openalex': 'https://openalex.org/W1984342562', 'doi': 'https://doi.org/10.1586/14779072.5.1.45', 'mag': '1984342562', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17187456'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1586/14779072.5.1.45', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S108504264', 'display_name': 'Expert Review of Cardiovascular Therapy', 'issn_l': '1477-9072', 'issn': ['1477-9072', '1744-8344'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5086743821', 'display_name': 'Marco Cattaneo', 'orcid': 'https://orcid.org/0000-0002-7343-4534'}, 'institutions': [{'id': 'https://openalex.org/I189158943', 'display_name': 'University of Milan', 'ror': 'https://ror.org/00wjc7c48', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I189158943']}], 'countries': ['IT'], 'is_corresponding': True, 'raw_author_name': 'Marco Cattaneo', 'raw_affiliation_strings': ['Università degli Studi di Milano, Unità di Ematologia e Trombosi-Ospedale San Paolo, Via di Rudinì 820142 Milano, Italy.'], 'affiliations': [{'raw_affiliation_string': 'Università degli Studi di Milano, Unità di Ematologia e Trombosi-Ospedale San Paolo, Via di Rudinì 820142 Milano, Italy.', 'institution_ids': ['https://openalex.org/I189158943']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5086743821'], 'corresponding_institution_ids': ['https://openalex.org/I189158943'], 'apc_list': None, 'apc_paid': None, 'fwci': 2.483, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 86, 'citation_normalized_percentile': {'value': 0.999079, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '5', 'issue': '1', 'first_page': '45', 'last_page': '55'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy in Cardiovascular Disease', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy in Cardiovascular Disease', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 0.9759, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13489', 'display_name': 'Synthesis and Applications of ß-Lactams', 'score': 0.9735, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/platelet-reactivity', 'display_name': 'Platelet Reactivity', 'score': 0.533953}, {'id': 'https://openalex.org/keywords/fibrinolytic-agent', 'display_name': 'Fibrinolytic agent', 'score': 0.42140394}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9623928}, {'id': 'https://openalex.org/C2777015399', 'wikidata': 'https://www.wikidata.org/wiki/Q4775337', 'display_name': 'Antithrombotic', 'level': 2, 'score': 0.8213123}, {'id': 'https://openalex.org/C89560881', 'wikidata': 'https://www.wikidata.org/wiki/Q101026', 'display_name': 'Platelet', 'level': 2, 'score': 0.51721585}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.5166012}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.44109103}, {'id': 'https://openalex.org/C2909817843', 'wikidata': 'https://www.wikidata.org/wiki/Q575222', 'display_name': 'Fibrinolytic agent', 'level': 3, 'score': 0.42140394}, {'id': 'https://openalex.org/C2909112448', 'wikidata': 'https://www.wikidata.org/wiki/Q721432', 'display_name': 'Platelet aggregation inhibitor', 'level': 3, 'score': 0.42103612}, {'id': 'https://openalex.org/C2777849778', 'wikidata': 'https://www.wikidata.org/wiki/Q410237', 'display_name': 'Clopidogrel', 'level': 3, 'score': 0.41037825}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3461324}, {'id': 'https://openalex.org/C164705383', 'wikidata': 'https://www.wikidata.org/wiki/Q10379', 'display_name': 'Cardiology', 'level': 1, 'score': 0.32037574}, {'id': 'https://openalex.org/C2777628954', 'wikidata': 'https://www.wikidata.org/wiki/Q18216', 'display_name': 'Aspirin', 'level': 2, 'score': 0.24782598}], 'mesh': [{'descriptor_ui': 'D001792', 'descriptor_name': 'Blood Platelets', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D003327', 'descriptor_name': 'Coronary Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D005343', 'descriptor_name': 'Fibrinolytic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018048', 'descriptor_name': 'Receptors, Purinergic P2', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000241', 'descriptor_name': 'Adenosine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000249', 'descriptor_name': 'Adenosine Monophosphate', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000249', 'descriptor_name': 'Adenosine Monophosphate', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000249', 'descriptor_name': 'Adenosine Monophosphate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000249', 'descriptor_name': 'Adenosine Monophosphate', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D000789', 'descriptor_name': 'Angina, Unstable', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D000789', 'descriptor_name': 'Angina, Unstable', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001792', 'descriptor_name': 'Blood Platelets', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': False}, {'descriptor_ui': 'D001792', 'descriptor_name': 'Blood Platelets', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077144', 'descriptor_name': 'Clopidogrel', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003327', 'descriptor_name': 'Coronary Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003328', 'descriptor_name': 'Coronary Thrombosis', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D003328', 'descriptor_name': 'Coronary Thrombosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005343', 'descriptor_name': 'Fibrinolytic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009203', 'descriptor_name': 'Myocardial Infarction', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D009203', 'descriptor_name': 'Myocardial Infarction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D010974', 'descriptor_name': 'Platelet Aggregation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010974', 'descriptor_name': 'Platelet Aggregation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068799', 'descriptor_name': 'Prasugrel Hydrochloride', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058919', 'descriptor_name': 'Purinergic P2 Receptor Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016032', 'descriptor_name': 'Randomized Controlled Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018048', 'descriptor_name': 'Receptors, Purinergic P2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018048', 'descriptor_name': 'Receptors, Purinergic P2', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D058469', 'descriptor_name': 'Receptors, Purinergic P2X', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013577', 'descriptor_name': 'Syndrome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077486', 'descriptor_name': 'Ticagrelor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1586/14779072.5.1.45', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S108504264', 'display_name': 'Expert Review of Cardiovascular Therapy', 'issn_l': '1477-9072', 'issn': ['1477-9072', '1744-8344'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17187456', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.78, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 65, 'referenced_works': ['https://openalex.org/W1553345686', 'https://openalex.org/W1863971743', 'https://openalex.org/W1939515787', 'https://openalex.org/W1968967315', 'https://openalex.org/W1970488832', 'https://openalex.org/W1971915776', 'https://openalex.org/W1985449894', 'https://openalex.org/W1985927027', 'https://openalex.org/W1990163182', 'https://openalex.org/W1991655882', 'https://openalex.org/W1992168784', 'https://openalex.org/W2001688139', 'https://openalex.org/W2002821107', 'https://openalex.org/W2003593234', 'https://openalex.org/W2004282319', 'https://openalex.org/W2014626077', 'https://openalex.org/W2015975751', 'https://openalex.org/W2021880542', 'https://openalex.org/W2031833839', 'https://openalex.org/W2032959386', 'https://openalex.org/W2036731085', 'https://openalex.org/W2041936661', 'https://openalex.org/W2043670845', 'https://openalex.org/W2047088941', 'https://openalex.org/W2048670782', 'https://openalex.org/W2050417355', 'https://openalex.org/W2053379248', 'https://openalex.org/W2059136191', 'https://openalex.org/W2060258953', 'https://openalex.org/W2065258513', 'https://openalex.org/W2067034884', 'https://openalex.org/W2079463705', 'https://openalex.org/W2083535292', 'https://openalex.org/W2090899812', 'https://openalex.org/W2100209149', 'https://openalex.org/W2104549091', 'https://openalex.org/W2107797912', 'https://openalex.org/W2121047179', 'https://openalex.org/W2128978853', 'https://openalex.org/W2131470908', 'https://openalex.org/W2133991763', 'https://openalex.org/W2136229214', 'https://openalex.org/W2139891259', 'https://openalex.org/W2144512539', 'https://openalex.org/W2148132508', 'https://openalex.org/W2150912899', 'https://openalex.org/W2156130479', 'https://openalex.org/W2156506897', 'https://openalex.org/W2157123954', 'https://openalex.org/W2157518434', 'https://openalex.org/W2159023925', 'https://openalex.org/W2159193915', 'https://openalex.org/W2162886638', 'https://openalex.org/W2163050713', 'https://openalex.org/W2163170969', 'https://openalex.org/W2212838299', 'https://openalex.org/W2318352361', 'https://openalex.org/W2327850977', 'https://openalex.org/W2329490408', 'https://openalex.org/W2336413601', 'https://openalex.org/W2417402918', 'https://openalex.org/W2529190803', 'https://openalex.org/W311320695', 'https://openalex.org/W4241296915', 'https://openalex.org/W4247013331'], 'related_works': ['https://openalex.org/W3031301203', 'https://openalex.org/W2809722890', 'https://openalex.org/W2502259208', 'https://openalex.org/W2435828465', 'https://openalex.org/W2416781546', 'https://openalex.org/W2407593496', 'https://openalex.org/W2378905954', 'https://openalex.org/W2129387589', 'https://openalex.org/W2053354922', 'https://openalex.org/W2043264212'], 'abstract_inverted_index': {'Platelets': [0], 'possess': [1], 'three': [2], 'P2': [3], 'receptors': [4, 29], 'for': [5, 117, 207, 214], 'adenine': [6, 24], 'nucleotides:': [7], 'P2Y1': [8], 'and': [9, 15, 93, 146, 161, 166, 172, 210, 220], 'P2Y12,': [10], 'which': [11, 17, 140, 177], 'interact': [12], 'with': [13, 19, 26, 128, 152, 198], 'ADP,': [14, 208], 'P2X1,': [16, 216], 'interacts': [18], 'ATP.': [20], 'The': [21, 36], 'interaction': [22], 'of': [23, 41, 50, 68, 73, 126, 149, 174, 188, 202, 211], 'nucleotides': [25], 'their': [27], 'platelet': [28, 43, 175, 189, 205], 'plays': [30], 'an': [31, 39, 89, 108], 'important': [32, 62, 109], 'role': [33], 'in': [34, 53, 78, 104], 'thrombogenesis.': [35], 'thienopyridine': [37], 'ticlopidine,': [38, 85], 'antagonist': [40], 'the': [42, 48, 100, 114, 123, 203, 212], 'P2Y12': [44, 163], 'ADP': [45], 'receptor,': [46], 'reduces': [47], 'incidence': [49, 67], 'vascular': [51], 'events': [52], 'patients': [54, 127], 'at': [55], 'risk,': [56], 'but': [57], 'it': [58, 87], 'also': [59], 'has': [60, 83], 'some': [61], 'drawbacks:': [63], 'a': [64], 'relatively': [65], 'high': [66, 75, 101], 'toxic': [69, 96], 'effects;': [70], 'delayed': [71], 'onset': [72, 148, 171], 'action;': [74], 'inter-individual': [76], 'variability': [77, 103], 'response.': [79], 'Another': [80], 'thienopyridine,': [81], 'clopidogrel,': [82, 153], 'superseded': [84], 'because': [86], 'is': [88, 94, 141, 154], 'efficacious': [90], 'antithrombotic': [91, 226], 'drug': [92], 'less': [95], 'than': [97], 'ticlopidine.': [98], 'However,': [99], 'inter-patient': [102], 'response': [105], 'still': [106], 'remains': [107], 'issue.': [110], 'These': [111], 'drawbacks': [112], 'justify': [113], 'continuing': [115], 'search': [116], 'agents': [118], 'that': [119], 'can': [120], 'further': [121], 'improve': [122], 'clinical': [124, 157], 'outcome': [125], 'atherosclerosis': [129], 'through': [130], 'greater': [131], 'efficacy': [132], 'and/or': [133], 'safety.': [134], 'A': [135], 'new': [136, 199], 'thienopyridyl': [137], 'compound': [138], 'prasugrel,': [139], 'characterized': [142], 'by': [143], 'higher': [144], 'potency': [145], 'faster': [147], 'action': [150], 'compared': [151], 'currently': [155], 'under': [156, 218], 'evaluation.': [158], 'Two': [159], 'direct': [160], 'reversible': [162], 'antagonists,': [164], 'cangrelor': [165], 'AZD6140,': [167], 'have': [168], 'very': [169], 'rapid': [170, 186], 'reversal': [173, 194], 'inhibition,': [176], 'make': [178], 'them': [179], 'attractive': [180], 'alternatives': [181], 'to': [182, 223], 'thienopyridines,': [183], 'especially': [184], 'when': [185], 'inhibition': [187], 'aggregation': [190], 'or': [191], 'its': [192], 'quick': [193], 'are': [195, 217], 'required.': [196], 'Along': [197], 'P2Y12antagonists,': [200], 'inhibitors': [201], 'other': [204], 'receptor': [206, 213], 'P2Y1,': [209], 'ATP,': [215], 'development': [219], 'may': [221], 'prove': [222], 'be': [224], 'effective': [225], 'agents.': [227]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1984342562', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 6}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 3}, {'year': 2013, 'cited_by_count': 9}, {'year': 2012, 'cited_by_count': 3}], 'updated_date': '2024-08-31T15:28:09.701537', 'created_date': '2016-06-24'}